Evidence map›Paper›PMID 29740179›Full record

Observational studyBone marrow transplantation2018

Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.

Takahiko Sato, Aika Seto, Yusuke Kagaya, Naomi Kawashima, Daisuke Koyama, Takanobu Morishita, Yukiyasu Ozawa, Koichi Miyamura, Takeo Yamaguchi, Jun-Ichi Haruta and 1 more

Abstract readLetterObservational Study
PubMed Publisher
In one paragraph

Observational study in Bone marrow transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takahiko SatoDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Aika SetoDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yusuke KagayaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Naomi KawashimaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Daisuke KoyamaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Takanobu MorishitaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yukiyasu OzawaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Koichi MiyamuraDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Takeo YamaguchiDepartment of Gastroenterology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Jun-Ichi HarutaDepartment of Gastroenterology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Masafumi ItoDepartment of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. itom@nagoya-1st.jrc.or.jp.ORCID http://orcid.org/0000-0002-3553-4104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Esophageal NeoplasmsHematopoietic Stem Cell TransplantationNeoplasms, Second PrimaryStaining and LabelingAdolescentAdultBiomarkers, TumorChildChild, PreschoolCyclin-Dependent Kinase Inhibitor p16FemaleHumansImmunohistochemistryInfantIodineMaleBiomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Iodine

Identifiers

PMID29740179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.